Rescriptor and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Rescriptor (delavirdine mesylate), especially for people who are male, 50-59 old, also take Zerit, and have Hiv infection.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Rescriptor. It is created by eHealthMe based on reports of 426 people who have side effects when taking Rescriptor from the FDA, and is updated regularly.

What is Rescriptor?

Rescriptor has active ingredients of delavirdine mesylate. eHealthMe is studying from 426 Rescriptor users. Check the latest studies of Rescriptor.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,404 drugs and 3,350 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.

On Jun, 23, 2026

426 people reported to have side effects when taking Rescriptor.
Among them, 17 people (3.99%) have Swallowing difficulty.

Could Rescriptor cause Swallowing difficulty?

Among these 17 people:

What is the gender of people who have Swallowing difficulty when taking Rescriptor? *

female: 0.0 %
male: 100 %

What is the age of people who have Swallowing difficulty when taking Rescriptor? *

What are other drugs people take besides Rescriptor? *

What are other side effects people have besides Swallowing difficulty? *

Mitochondrial Toxicity (a condition in which the mitochondria of a body's cells become damaged or decline significantly in number;): 17 people, 100.00%
Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 17 people, 100.00%
Eyelid Ptosis (falling of the upper or lower eyelid): 17 people, 100.00%
Diplopia (double vision): 17 people, 100.00%
Blood Lactic Acid Increased: 17 people, 100.00%
Ophthalmoplegia (a paralysis or weakness of one or more of the muscles that control eye movement): 16 people, 94.12%
Progressive External Ophthalmoplegia (eye disorder characterized by slowly progressive inability to move the eyes and eyebrows): 12 people, 70.59%
Extraocular Muscle Paresis (nerve paralysis outside of eye tissue): 8 people, 47.06%

What are the existing conditions these people have? *

Hiv Infection: 17 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Rescriptor and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rescriptor:

Rescriptor (426 reports)

Browse all side effects of Rescriptor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Swallowing difficulty (2,404 drugs)

Browse all the conditions that are associated with Swallowing difficulty:

Swallowing difficulty (3,350 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on delavirdine mesylate (the active ingredients of Rescriptor) and Rescriptor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.